MICROBOT MEDICAL INC. Cash and Restricted Cash
MICROBOT MEDICAL INC. (MBOT) had Cash and Restricted Cash of $3.42 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.42M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.76M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.13M.
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $527.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $3.42M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $6.76M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.13M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $527.00K 10-Q · filed 2025-11-12 |
| 2024-06-30 | $2.51M 10-Q · filed 2025-08-12 |
| 2019-06-30 | $9.13M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $9.61M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $5.26M 10-Q · filed 2019-08-14 |
| 2018-09-30 | $6.70M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $8.05M 10-Q · filed 2019-08-14 |
| 2018-03-31 | $9.49M 10-Q · filed 2019-05-15 |
| 2017-12-31 | $10.81M 10-Q · filed 2019-08-14 |
| 2017-09-30 | $11.76M 10-Q · filed 2018-11-14 |
| 2017-06-30 | $13.08M 10-Q · filed 2018-08-14 |
| 2017-03-31 | $5.00M 10-Q · filed 2018-08-14 |
| 2016-12-31 | $2.71M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |